![](/img/cover-not-exists.png)
Oral administration of KW-5092, a novel gastroprokinetic agent with acetylcholinesterase inhibitory and acetylcholine release enhancing activities, causes a dose-dependent increase in the blood acetylcholine content of beagle dogs
Shin Yamada, Takeshi Fujii, Koichiro KawashimaVolume:
225
Year:
1997
Language:
english
DOI:
10.1016/s0304-3940(97)00188-2
File:
PDF, 121 KB
english, 1997